314 related articles for article (PubMed ID: 31544046)
1. Comparison of conbercept and ranibizumab for the treatment efficacy of diabetic macular edema: a Meta-analysis and systematic review.
Liu WS; Li YJ
Int J Ophthalmol; 2019; 12(9):1479-1486. PubMed ID: 31544046
[TBL] [Abstract][Full Text] [Related]
2. A systematic review and meta-analysis to compare the efficacy of conbercept with ranibizumab in patients with macular edema secondary to retinal vein occlusion.
Liu W; Li Y; Cao R; Bai Z; Liu W
Medicine (Baltimore); 2020 May; 99(21):e20222. PubMed ID: 32481293
[TBL] [Abstract][Full Text] [Related]
3. Efficiency and safety of laser photocoagulation with or without intravitreal ranibizumab for treatment of diabetic macular edema: a systematic review and Meta-analysis.
Qian TW; Zhao MY; Li XX; Xu X
Int J Ophthalmol; 2017; 10(7):1134-1143. PubMed ID: 28730118
[TBL] [Abstract][Full Text] [Related]
4. Different Anti-Vascular Endothelial Growth Factor for Patients With Diabetic Macular Edema: A Network Meta-Analysis.
Wang X; He X; Qi F; Liu J; Wu J
Front Pharmacol; 2022; 13():876386. PubMed ID: 35814207
[No Abstract] [Full Text] [Related]
5. One-Year Effectiveness Study of Intravitreously Administered Conbercept
Wang H; Guo J; Tao S; Wang X; Liu X; Li T; Wang J; Yang X; Niu T; Liu D
Diabetes Ther; 2020 May; 11(5):1103-1117. PubMed ID: 32236812
[TBL] [Abstract][Full Text] [Related]
6. Conbercept for Treatment of Neovascular Age-Related Macular Degeneration and Visual Impairment due to Diabetic Macular Edema or Pathologic Myopia Choroidal Neovascularization: A Systematic Review and Meta-Analysis.
Zhou P; Zheng S; Wang E; Men P; Zhai S
Front Pharmacol; 2021; 12():696201. PubMed ID: 34712132
[No Abstract] [Full Text] [Related]
7. Comparison of efficacy of conbercept, aflibercept, and ranibizumab ophthalmic injection in the treatment of macular edema caused by retinal vein occlusion: a Meta-analysis.
Xing Q; Dai YN; Huang XB; Peng L
Int J Ophthalmol; 2023; 16(7):1145-1154. PubMed ID: 37465496
[TBL] [Abstract][Full Text] [Related]
8. Macular laser photocoagulation with or without intravitreal triamcinolone pretreatment for diabetic macular edema: a result from five randomized controlled trials.
Liu XD; Zhou XD; Wang Z; Shen YM
Int J Ophthalmol; 2016; 9(1):132-8. PubMed ID: 26949623
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 12-month therapeutic effect of conbercept and ranibizumab for diabetic macular edema: a real-life clinical practice study.
Xu Y; Rong A; Xu W; Niu Y; Wang Z
BMC Ophthalmol; 2017 Aug; 17(1):158. PubMed ID: 28841827
[TBL] [Abstract][Full Text] [Related]
10. Ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema: a meta-analysis of randomized controlled trials.
Chen G; Li W; Tzekov R; Jiang F; Mao S; Tong Y
PLoS One; 2014; 9(12):e115797. PubMed ID: 25541937
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal Ranibizumab Versus Intravitreal Ranibizumab Combined with Posterior Subtenon Triamcinolone Acetonide in Diabetic Macular Edema.
Karatas G; Erden B; Cakir A; Bolukbasi S; Erdenoz S; Argon BD; Elcioglu MN
Beyoglu Eye J; 2021; 6(3):229-235. PubMed ID: 35005521
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone implant as an adjuvant therapy to ranibizumab loading dose in persistent diabetic macular edema.
Cakir A; Erden B; Bolukbasi S; Bayat AH; Ozturan SG; Elcioglu MN
Int Ophthalmol; 2019 Oct; 39(10):2179-2185. PubMed ID: 30470985
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the Efficacy and Safety of Intravitreal Conbercept with Intravitreal Ranibizumab for Treatment of Diabetic Macular Edema: A Meta-Analysis.
Sun X; Zhang J; Tian J; Chen S; Zeng F; Yuan G
J Ophthalmol; 2020; 2020():5809081. PubMed ID: 32280526
[TBL] [Abstract][Full Text] [Related]
14. Effects of Novel Anti-VEGF Agents with Intravitreal Conbercept in Diabetic Retinopathy: A Systematic Review and Meta-Analysis.
Wang H; Zhou J; Sun C; Dong X
Evid Based Complement Alternat Med; 2021; 2021():9357108. PubMed ID: 33623533
[TBL] [Abstract][Full Text] [Related]
15. Switching to Conbercept in Diabetic Macular Edema After Unsatisfactory Response to Previous Intravitreal Injection of Ranibizumab.
Xing P; Meng B; Hu X; Qu W; Wang S
Clin Ophthalmol; 2023; 17():3491-3497. PubMed ID: 38026602
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Effectiveness of Intravitreal Ranibizumab for Diabetic Macular Edema in Vitrectomized and Nonvitrectomized Eyes.
Koyanagi Y; Yoshida S; Kobayashi Y; Kubo Y; Yamaguchi M; Nakama T; Nakao S; Ikeda Y; Ohshima Y; Ishibashi T; Sonoda KH
Ophthalmologica; 2016; 236(2):67-73. PubMed ID: 27362944
[TBL] [Abstract][Full Text] [Related]
17. One-Year Outcome of Conbercept Therapy for Diabetic Macular Edema.
Li F; Zhang L; Wang Y; Xu W; Jiao W; Ma A; Zhao B
Curr Eye Res; 2018 Feb; 43(2):218-223. PubMed ID: 29265939
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of intravitreal ranibizumab for diabetic macular edema in vitrectomized versus non-vitrectomized eyes: a Meta-analysis.
Wang YH; Xu Q; Luan J
Int J Ophthalmol; 2024; 17(4):729-735. PubMed ID: 38638245
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal ranibizumab (lucentis) for the treatment of diabetic macular edema: a systematic review and meta-analysis of randomized clinical control trials.
Wang H; Sun X; Liu K; Xu X
Curr Eye Res; 2012 Aug; 37(8):661-70. PubMed ID: 22631452
[TBL] [Abstract][Full Text] [Related]
20. Ranibizumab for macular edema secondary to retinal vein occlusion: a meta-analysis of dose effects and comparison with no anti-VEGF treatment.
Song WT; Xia XB
BMC Ophthalmol; 2015 Mar; 15():31. PubMed ID: 25881069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
